Shortcuts
Please wait while page loads.
SISSA Library . Default .
PageMenu- Main Menu-
Page content

Catalogue Display

Frontiers of Biostatistical Methods and Applications in Clinical Oncology

Frontiers of Biostatistical Methods and Applications in Clinical Oncology
Catalogue Information
Field name Details
Dewey Class 519.5
Title Frontiers of Biostatistical Methods and Applications in Clinical Oncology ([EBook]) / edited by Shigeyuki Matsui, John Crowley.
Added Personal Name Matsui, Shigeyuki
Crowley, John
Other name(s) SpringerLink (Online service)
Publication Singapore : Springer Singapore , 2017.
Physical Details XIII, 438 pages. 89 illus. : online resource.
ISBN 9789811001260
Summary Note This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in the midst of evolution owing to rapid advances in biotechnologies and cancer genomics, is becoming one of the most promising disease fields in the shift toward personalized medicine. Modern developments of diagnosis and therapeutics of cancer have also been continuously fueled by recent progress in establishing the infrastructure for conducting more complex, large-scale clinical trials and observational studies. The field of cancer clinical studies therefore will continue to provide many new statistical challenges that warrant further progress in the methodology and practice of biostatistics. This book provides a systematic coverage of various stages of cancer clinical studies. Topics from modern cancer clinical trials include phase I clinical trials for combination therapies, exploratory phase II trials with multiple endpoints/treatments, and confirmative biomarker-based phase III trials with interim monitoring and adaptation. It also covers important areas of cancer screening, prognostic analysis, and the analysis of large-scale molecular data in the era of big data.:
Contents note 1. Phase I clinical trials -- 2. Phase II clinical trials -- 3. Phase III clinical trials -- 4. Evaluation of surrogate endpoints -- 5. Disease Screening/development of diagnosis -- 6. Analysis of omics data (genomic signature developments etc) -- 7. Causal inference in clinical trials and observational studies.
System details note Online access to this digital book is restricted to subscription institutions through IP address (only for SISSA internal users)
Internet Site http://dx.doi.org/10.1007/978-981-10-0126-0
Links to Related Works
Subject References:
Authors:
Corporate Authors:
Classification:
Catalogue Information 38254 Beginning of record . Catalogue Information 38254 Top of page .

Reviews


This item has not been rated.    Add a Review and/or Rating38254
Quick Search